Avalo Therapeutics grants inducement equity awards to six new employees
Avalo Therapeutics announced inducement equity awards to six new employees under Nasdaq Listing Rule 5635(c)(4).
WAYNE, Pa., Sept.
04, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc.
NASDAQ:AVTX, a clinical stage biotechnology company dedicated to developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases, today announced the grant of inducement equity awards to six new em…